Head of the Department
Head of the DepartmentProf. Dr. Christine von Arnim
ORCIDResearch GatePubMed

Education

  • 1997, University of Freiburg i.Br.
    MD (Staatsexamen), Medicine
  • 1997, Medical School Freiburg
    MD thesis (Dr. med.), Molecular biology in Psychiatry
  • 2003, Ulm University
    Board certification, Neurology
  • 2006, Ulm University
    Venia legend (Habilitation), Alzheimer’s disease
  • 2007, Ulm University
    Board certification, Geriatrics
  • 2008, Ulm University
    Associate Professor (Apl.), Neurology
  • 2010, Ulm University
    Board certification, Palliative Care
  • 2011, Ulm University
    Board certification, Intensive Care medicine
  • 2016, Ulm University
    Board certification, Rehabilitation medicine
  • 2019, Ulm University
    Board certification, Social medicine and public health

Scientific Training / Past Positions

  • 1997-1998 Resident, Klinikum Mannheim, Universität Heidelberg (Prof. Hennerici)
  • 1998-2003 Resident, Ulm University (Prof. A.C. Ludolph)
  • 2003-2005 Postdoctoral research fellow (DFG), Massachusetts General Hospital, Harvard Medical School, Charlestown, USA (Prof. B.T. Hyman)
  • 2005-2018 Senior consultant, Head of memory clinic, Independent research group leader, Ulm University, Dept. of Neurology (Prof. A.C. Ludolph)
  • 2016-2019 Head, Clinic for Neurogeriatrics and Neurological Rehabilitation, University- and Rehabilitation Hospital Ulm
  • 2019-present Chair, Director of the Division of Geriatrics, University Medical Center Göttingen, Georg-August-University Göttingen, Germany

Organisation / Management

  • 2006-2017 Secretary “Geriatrisches Zentrum Ulm (GZU)
  • 2006-2018 National coordinator and principal investigator in clinical AD and MCI trials
  • 2012-2019 Federführende Vertrauensdozentin „Deutsche Studienstiftung“

Funding and research areas

  • Grants, DFG, Landesstiftung Baden-Württemberg, Alzheimer Forschungs Initiative e.V., Hirnliga e.V., WIN-Kolleg stipend of the Heidelberger Akademie der Wissenschaften, AIF, BMG (Leuchtturm Demenz – Ultdem), Innovationsfond (GBA), State of Baden-Württemberg (Sonderlinie), > 2.5 Mio Euro
  • Research areas, Clinical diagnosis and treatment of neurodegenerative diseases and delirium, Neurogeriatrics, Heart & Brain. Biomarker research and clinical trials.

Honors and Awards

  • 2005 Poster Award, Annual Meeting of the German Society for Neurology, Wiesbaden
  • Since 2007 Member of the Academy College (WIN College) of the Heidelberg Academy of Sciences and Humanities, „Heidelberger Akademie der Wissenschaften“
  • 2008 Award for the Advancement of Women in Science, Ulm University
  • 2016 Finalist Otto-von-Guericke award, German Fed. of Industrial Research Associations – AiF
  • 2018 University-Industry Cooperation Award 2017 Ulm University

Memberships

  • DGG – Deutsche Gesellschaft für Geriatrie (DGG) – Since September 2017: Speaker AG Neurologie
  • Hirnliga e.V. – Scientific board member
  • SFN – Society for Neuroscience
  • AAN – American Academy for Neurology
  • DGN – Deutsche Gesellschaft für Neurologie
  • EMCA – European Memory Clinic Association

Major Grants (since 2015)

  • Innovationsfond (GBA), PAWEL: Patientensicherheit,  Wirtschaftlichkeit und Lebensqualität: Reduktion von Delirrisiko und POCD nach Elektivoperationen im Alter, 2017-2021
  • Boehringer Ingelheim Ulm University Biocenter (BIU), Pathophysiological and diagnostic role of cGMP-dependent pathways in Alzheimer’s disease II; 2016-2019
  • Sonderlinie Medizin – Verbundvorhaben (Land Baden-Württemberg), Medikation und Lebenssituation im Alter, 2016-2018
  • Industrielle Gemeinschaftsforschung (BMWi) IGF-Projekt: 18239 N, Mitoskopie -Mitochondriales Monitoring von Stoffwechseländerungen bei neurologischen Erkrankungen mittels optischer Systeme; 2014-2016
  • Boehringer Ingelheim Ulm University Biocenter (BIU), Pathophysiological and diagnostic role of cGMP-dependent pathways in Alzheimer’s disease; 2012-2015